News and Views

Genetics & Genomics

Genetic Disorder Reference Sheet: PTEN Hamartoma Tumor Syndrome

Alterations in the phosphatase and tensin (PTEN) homologue gene result in PTEN hamartoma tumor syndrome, which includes Cowden, Bannayan-Riley-Ruvalcaba, and PTEN-related Proteus and Proteus-like syndromes. Pathogenic variants in the PTEN gene are associated with increased risk for developing multiple benign and malignant tumors, some of which may occur in childhood.

Trending Topics

View All Topics

FDA Approves Dabrafenib With Trametinib for Pediatric Patients With Low-Grade Glioma and a BRAF V600E Variant

U.S. Food and Drug Administration (FDA)

FDA Approves Dabrafenib With Trametinib for Pediatric Patients With Low-Grade Glioma and a BRAF V600E Variant

Transgender Patients, Deadnaming, and Patient Identification

Patient Advocacy

Transgender Patients, Deadnaming, and Patient Identification

RNs Need More Education About Reasonable Accommodations for Patients With Intellectual Disabilities

Specific Populations

RNs Need More Education About Reasonable Accommodations for Patients With Intellectual Disabilities

Four R’s and Resilience Approach Help Oncology Nurses Respond to Morally Distressing Challenges

Four R’s and Resilience Approach Help Oncology Nurses Respond to Morally Distressing Challenges

Watch Your Words to Lose the Weight Bias in Health Care

Nursing Education

Watch Your Words to Lose the Weight Bias in Health Care

FDA Expands Early Breast Cancer Indication for Abemaciclib With Endocrine Therapy

U.S. Food and Drug Administration (FDA)

FDA Expands Early Breast Cancer Indication for Abemaciclib With Endocrine Therapy

Disability Disparities in Cancer Care

Specific Populations

Disability Disparities in Cancer Care

Cancer Care’s Global Connections Turn Places Into People

Cancer Care’s Global Connections Turn Places Into People

What the Evidence Says About Tai Chi in Cancer Care

Integrative Medicine

What the Evidence Says About Tai Chi in Cancer Care

Gamification Helps Oncology Nurses Retain Their Cancer Knowledge and Best Practices

Oncology Nurse Education

Gamification Helps Oncology Nurses Retain Their Cancer Knowledge and Best Practices

Oncology Drug Reference Sheet: Futibatinib

Drug Reference Sheets

Oncology Drug Reference Sheet: Futibatinib

February 28, 2023

The Power of Reading on a Nurse’s Well-Being

Nurse Well-Being

The Power of Reading on a Nurse’s Well-Being

February 23, 2023

Tip Sheet Helps Nurses Confront Systemic Racism by Providing Equitable Hair Care

Patient Empowerment

Tip Sheet Helps Nurses Confront Systemic Racism by Providing Equitable Hair Care

February 22, 2023

Direct-to-Consumer Genomic Testing in Patients With Cancer

Genetics & Genomics

Direct-to-Consumer Genomic Testing in Patients With Cancer

February 21, 2023

Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment

Clinical Practice

Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment

February 15, 2023

Danya Garner Selected as 2023–2024 ONS President

Danya Garner Selected as 2023–2024 ONS President

February 14, 2023

Postdischarge ICI Patient Education Eliminates Hospital Readmissions

Postdischarge ICI Patient Education Eliminates Hospital Readmissions

February 14, 2023

FDA Grants Regular Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

February 10, 2023

Rejuvenate, Refocus, and Revitalize Your Practice and Yourself at the 48th Annual ONS Congress®

Rejuvenate, Refocus, and Revitalize Your Practice and Yourself at the 48th Annual ONS Congress®

February 10, 2023

Oncology Providers Can Transform the Trajectory of Financial Toxicity

Advanced Practice Nursing (APRN)

Oncology Providers Can Transform the Trajectory of Financial Toxicity

February 09, 2023

Nearly 25% of Patients With Cancer Are Victims of Intimate Partner Violence

Nearly 25% of Patients With Cancer Are Victims of Intimate Partner Violence

February 08, 2023

Smiths Medical Recalls More Than 19 Million CADD System Administration Sets and Cassette Reservoirs Because of Medication Delivery Issues

U.S. Food and Drug Administration (FDA)

Smiths Medical Recalls More Than 19 Million CADD System Administration Sets and Cassette Reservoirs Because of Medication Delivery Issues

February 07, 2023

How Nurses and Administrators Can Respond to the Prevalence of Violence in Health Care

Culture of Safety

How Nurses and Administrators Can Respond to the Prevalence of Violence in Health Care

February 07, 2023

Violence in Nursing

Clinical Practice

Violence in Nursing

February 07, 2023

FDA Approves Sacituzumab Govitecan-Hziy for HR-Positive Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Sacituzumab Govitecan-Hziy for HR-Positive Breast Cancer

February 06, 2023

What Do You Value as an ONS Member?

What Do You Value as an ONS Member?

February 06, 2023

The Case of the Resistance Relevance

Oncology Nurse Influence

The Case of the Resistance Relevance

February 03, 2023

Use Motivational Interviewing to Tailor Your Conversations to Your Patients’ Unique Needs

Patient Education

Use Motivational Interviewing to Tailor Your Conversations to Your Patients’ Unique Needs

February 02, 2023

Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options

Specific Populations

Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options

February 01, 2023

FDA Approves Elacestrant for ER-Positive, HER2-Negative, ESR1-Variant Advanced or Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Elacestrant for ER-Positive, HER2-Negative, ESR1-Variant Advanced or Metastatic Breast Cancer

January 31, 2023

Mentorships Open Opportunities for Oncology Nurses’ Career Growth and Wellness

Nurse Well-Being

Mentorships Open Opportunities for Oncology Nurses’ Career Growth and Wellness

January 31, 2023

Focus on COVID-19 Prevention Intensifies for Patients With Cancer as FDA Removes Emergency Use Authorization for Evushield

U.S. Food and Drug Administration (FDA)

Focus on COVID-19 Prevention Intensifies for Patients With Cancer as FDA Removes Emergency Use Authorization for Evushield

January 30, 2023

FDA Approves Pembrolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

January 30, 2023

$FDA Grants Accelerated Approval to Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 30, 2023

Oncology Drug Reference Sheet: Darolutamide

Drug Reference Sheets

Oncology Drug Reference Sheet: Darolutamide

January 26, 2023

Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

Pancreatic Cancer

Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

January 25, 2023

Use Active Listening to Engage More Deeply in Patient Discussions

Cancer Research

Use Active Listening to Engage More Deeply in Patient Discussions

January 24, 2023

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

January 20, 2023

FDA Grants Accelerated Approval to Tucatinib With Trastuzumab for Colorectal Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tucatinib With Trastuzumab for Colorectal Cancer

January 20, 2023

Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI

Cancer Research

Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI

January 18, 2023

Genetic Disorder Reference Sheet: BAP1

Genetics & Genomics

Genetic Disorder Reference Sheet: BAP1

January 17, 2023

Religious Fasting During Cancer Treatment

Cultural Competency

Religious Fasting During Cancer Treatment

January 17, 2023

Smiths Medical Issues Urgent Medical Device Correction Letter About Potential Issues With CADD™ Infusion Sets

U.S. Food and Drug Administration (FDA)

Smiths Medical Issues Urgent Medical Device Correction Letter About Potential Issues With CADD™ Infusion Sets

January 12, 2023

Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration

U.S. Food and Drug Administration (FDA)

Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration

January 12, 2023

The Case of the Costly PARP Inhibitor

The Case of the PARP Inhibitor Adherence Assistance

January 12, 2023

Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities

Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities

January 11, 2023

Achieve Equity in Patient Communication With These Evidence-Based Approaches

Specific Populations

Achieve Equity in Patient Communication With These Evidence-Based Approaches

January 10, 2023

$FDA Grants Accelerated Approval to Mosunetuzumab-Axgb for Relapsed or Refractory Follicular Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Mosunetuzumab-Axgb for Relapsed or Refractory Follicular Lymphoma

January 06, 2023

Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment

Specific Populations

Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment

January 05, 2023

Back to Top ▲